Pharmaceuticals, Biotechnology and Life Sciences
Anti-TROP-2 coupled to SN38 (a DNA polymerase inhibitor) (ESG-401) has received approval to begin clinical trials.ESG-401 addresses a highly unmet…
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 21, 2021 – Genmab A/S (Nasdaq: GMAB) announces under…
BURBANK, CA, July 21, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medolife Rx, Inc. (“Medolife”), a global integrated bioceutical company with R&D,…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, July 21, 2021 (GLOBE…
COVID-19 patients with newly diagnosed SARS-CoV-2 infections were treated in this large Phase 2 efficacy trial in the United Kingdom.COVIDROPS™…
– Csiki has over two decades of experience in research and drug development of cancer immunotherapies -REDWOOD CITY, Calif., July…
NEWPORT, United Kingdom and AMSTERDAM, July 21, 2021 (GLOBE NEWSWIRE) — Nanopharm Ltd., an Aptar Pharma company and leader in…
EMERYVILLE, Calif., July 21, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI) today announced a strategic collaboration with Thermo…
NEW YORK, NY, July 21, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New…
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS21 JULY 2021 at 3:45 p.m. EEST Orion Corporation: Disclosure Under…